Data & AI

All resources

Filter by:
Current and anticipated future use of MRD in hematological and solid tumors​

This report explores the current and future use of minimal residual disease (MRD) testing, uncovering adoption trends, clinical applications, and commercial implications.

 
Data & AI Regulatory Insights
Complexity to Clarity: Using Multi-Modal Data to drive commercial success

Watch our webinar to explore how a multi-modal data approach can simplify complexities in precision medicine and enhance commercialization strategies for better patient outcomes.

Data & AI
Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

By Scott Phillips
Data & AI
Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision

Engage healthcare professionals effectively with data-driven strategies that enhance treatment decisions and improve patient outcomes in this informative online webinar.

HCP Engagement & Activation Data & AI
Episode 3: Targeted therapies in Gastric cancer: From clinic to labs  

Explore targeted therapies in gastric cancer through insights from a pathologist and oncologist in this episode of the Better Testing, Better Treatment podcast series.

Data & AI
Episode 4: Targeted therapies in cancer: From clinic to labs

Explore targeted cancer therapies from a European perspective in Episode 4 of the Better Testing, Better Treatment podcast, featuring insights from leading experts in the field.

Data & AI
Episode 5 Oncogenic Fusion detection and reporting in NSCLC and solid tumors

Explore the latest insights on oncogenic fusion detection and reporting in NSCLC and solid tumors from experts Dr. Solomon and Dr. Saxena in this informative podcast episode.

Data & AI
Episode 6 Artificial Intelligence in Prostate Cancer: from clinic to lab

Discover how AI enhances prostate cancer diagnostics and treatment in our podcast featuring experts Pr. Sophie Ferlicot and Dr. Mario Terlizzi.

Data & AI
Episode 7 Exploring Inherited Cancer: from clinic to lab

Discover how genetic testing for inherited cancer has evolved, transforming clinical practice and patient care, in episode 7 of the Better Testing, Better Treatment podcast.

Data & AI
Episode 8 The Pathology-Oncology Connection: Labs in Action

Explore how tailored testing and collaboration between labs and oncologists enhance diagnostic and treatment decisions in cancer care on the Better Testing, Better Treatment podcast.

Data & AI
ASCO 2026 Trends to Watch: Precision Oncology, AI and Real-World Impact

Explore key trends in precision oncology, AI integration, and real-world impact at ASCO 2026, focusing on biomarker-driven therapies and actionable insights for improved patient outcomes.

By Sarah Heming
Data & AI
AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

By Gosia Leitch
Data & AI
Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

By Sarah Heming
Data & AI
Precision for All: Watch the New Diaceutics Manifesto

Diaceutics empowers biopharma to enhance patient outcomes by providing data-driven solutions for diagnostic-driven therapies. Ensuring every eligible patient receives timely and  effective treatment.

By Sarah Heming
Commercial Strategy Optimization HCP Engagement & Activation Data & AI

Stay ahead with the diaceutics newsletter

Diagnostic-driven therapies are reshaping commercialization. Get evidence-based content, expert perspectives, and practical intelligence delivered straight to your inbox, every two weeks.

Ready to do commercialization differently?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.